Loading stock data…
SNYR
$0.32+0.01 (+2.70%)
Market ClosedLast close May 1
Synergy CHC Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SNYR in the Healthcare sector is trading at $0.32. The stock is currently near its 52-week low of $0.30, remaining 84.1% below its 200-day moving average. Technical signals show oversold RSI of 18 and bullish MACD crossover, explaining why SNYR maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 18) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.32
Potential Upside
5%
Whystock Fair Value$0.34
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
53.36%
Volume
Today's trading volume
452,713
Recent News
Synergy CHC Corp. Q4 2025 Earnings Call Summary
Moby summary of Synergy CHC Corp.'s Q4 2025 earnings call
Synergy CHC Corp (SNYR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing ...
Despite a challenging quarter with significant revenue declines, Synergy CHC Corp (SNYR) focuses on international expansion and retail growth to drive future success.
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) delivered earnings and revenue surprises of +7.09% and +0.52%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Synergy CHC Insider Ups Holding During Year
From what we can see, insiders were net buyers in Synergy CHC Corp.'s ( NASDAQ:SNYR ) during the past 12 months. That...
Synergy CHC Corp (SNYR) Q3 2025 Earnings Call Highlights: Growth in Revenue and Strategic ...
Despite a decline in net income, Synergy CHC Corp (SNYR) showcases robust revenue growth and strategic leadership moves to bolster future expansion.